We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of MRTX yet.

MRTX Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q2 2024, worth a combined $0 — down 100% from $2.52K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of MRTX and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Sachetta, exiting entirely with an estimated $1.41K sold.

  • 0 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q2 2024, down from 2 in Q1 2024.
  • Funds reported $0 of Mirati Therapeutics, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q2 2024 and 2 closed out, a net change of -2 holders.
  • The largest Mirati Therapeutics, Inc. Common Stock seller in Q2 2024 was Sachetta, an estimated $1.41K sold.

Based on aggregated 13F filings for Q2 2024.